Francesca Alfei

Documents
Combined JAK inhibition and PD-1 immunotherapy for non-small cell lung cancer patients
Combined JAK inhibition and PD-1 immunotherapy for non-small cell lung cancer patients
Intratumoral immune triads are required for immunotherapy-mediated elimination of solid tumors
Intratumoral immune triads are required for immunotherapy-mediated elimination of solid tumors